MAP2K7 and acute myeloid leukemia: Similarly, in a murine model of inv(16) AML driven by rearrangement of CBFB (core-binding factor subunit beta), NRASG12D blocked cell death through upregulation of Bmi and the MEK pathway, the latter rendering this AML sensitive to MEK inhibitors (Xue et al., 2014).